Literature DB >> 11373504

Neutrophil activation and acute lung injury.

W L Lee1, G P Downey.   

Abstract

Neutrophils are considered to be central to the pathogenesis of most forms of acute lung injury (ALI). For the sake of clarity, neutrophil involvement in ALI can be conceptualized as consisting of sequential stages, beginning with their sequestration in the pulmonary microvasculature, followed by adhesion and activation, and culminating in the production of a microbicidal or "effector" response, such as the generation of reactive oxygen species or release of proteolytic enzymes. Great strides have been made in elucidating these various stages of neutrophil involvement. Recent studies have focused on the intracellular signaling pathways that govern neutrophil activation and have elucidated complex cascades of kinases and other intracellular signaling molecules that allow for amplication of the neutrophil response, yet simultaneously confer specificity of a response. We believe that the inflammatory response in ALI may initially be adaptive, such as the pivotal role played by neutrophils in a bacterial or fungal infection. Ultimately, it is the persistence or the dysregulation of neutrophil activation that may lead to ALI. An increased understanding of how neutrophils function will facilitate the design of therapeutic strategies that retain the beneficial aspects of the inflammatory response, while avoiding unnecessary tissue damage.

Entities:  

Mesh:

Year:  2001        PMID: 11373504     DOI: 10.1097/00075198-200102000-00001

Source DB:  PubMed          Journal:  Curr Opin Crit Care        ISSN: 1070-5295            Impact factor:   3.687


  118 in total

1.  Neutrophils and lung injury: getting it right.

Authors:  Thomas R Martin
Journal:  J Clin Invest       Date:  2002-12       Impact factor: 14.808

2.  Critical role for CXCR2 and CXCR2 ligands during the pathogenesis of ventilator-induced lung injury.

Authors:  John A Belperio; Michael P Keane; Marie D Burdick; Vedang Londhe; Ying Ying Xue; Kewang Li; Roderick J Phillips; Robert M Strieter
Journal:  J Clin Invest       Date:  2002-12       Impact factor: 14.808

3.  Experimental Lung Injury Promotes Changes in Oxidative/Nitrative Status and Inflammatory Markers in Cerebral Cortex of Rats.

Authors:  Maira J da Cunha; Aline A da Cunha; Samanta O Loureiro; Fernanda R Machado; Felipe Schmitz; Janaína Kolling; Eduardo P Marques; Angela T S Wyse
Journal:  Mol Neurobiol       Date:  2014-11-04       Impact factor: 5.590

4.  Protection against sepsis-induced lung injury by selective inhibition of protein kinase C-δ (δ-PKC).

Authors:  Laurie E Kilpatrick; Stephen W Standage; Haiying Li; Nichelle R Raj; Helen M Korchak; Marla R Wolfson; Clifford S Deutschman
Journal:  J Leukoc Biol       Date:  2010-08-19       Impact factor: 4.962

Review 5.  The microbiome and critical illness.

Authors:  Robert P Dickson
Journal:  Lancet Respir Med       Date:  2015-12-12       Impact factor: 30.700

6.  Time course of metabolic activity and cellular infiltration in a murine model of acid-induced lung injury.

Authors:  Vanessa Zambelli; Giuseppe Di Grigoli; Margherita Scanziani; Silvia Valtorta; Maria Amigoni; Sara Belloli; Cristina Messa; Antonio Pesenti; Ferruccio Fazio; Giacomo Bellani; Rosa Maria Moresco
Journal:  Intensive Care Med       Date:  2012-01-26       Impact factor: 17.440

Review 7.  Endocrine regulation of lung disease and inflammation.

Authors:  Nathalie Fuentes; Patricia Silveyra
Journal:  Exp Biol Med (Maywood)       Date:  2018-12-03

8.  Feasibility of tissue plasminogen activator formulated for pulmonary delivery.

Authors:  John S Dunn; Rajiv Nayar; Jackie Campos; Brooks M Hybertson; Yue Zhou; Mark Cornell Manning; John E Repine; Kathleen A Stringer
Journal:  Pharm Res       Date:  2005-09-22       Impact factor: 4.200

9.  Cepharanthine, an alkaloid from Stephania cepharantha Hayata, inhibits the inflammatory response in the RAW264.7 cell and mouse models.

Authors:  Hailong Huang; Guixue Hu; Chunfeng Wang; Hao Xu; Xiaoqing Chen; Aidong Qian
Journal:  Inflammation       Date:  2014-02       Impact factor: 4.092

10.  Mirasol Pathogen Reduction Technology treatment does not affect acute lung injury in a two-event in vivo model caused by stored blood components.

Authors:  C C Silliman; S Y Khan; J Bradley Ball; M R Kelher; S Marschner
Journal:  Vox Sang       Date:  2009-11-25       Impact factor: 2.144

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.